Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharmaceutical Industries, Skechers USA, Chevron

Dallas, TX, based Investment company Penn Davis Mcfarland Inc buys Celgene, Bristol-Myers Squibb Company, sells Teva Pharmaceutical Industries, Skechers USA, Chevron, Fitbit, HCP during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Penn Davis Mcfarland Inc. As of 2017-03-31, Penn Davis Mcfarland Inc owns 32 stocks with a total value of $332 million. These are the details of the buys and sells.

For the details of PENN DAVIS MCFARLAND INC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=PENN+DAVIS+MCFARLAND+INC

These are the top 5 holdings of PENN DAVIS MCFARLAND INC
  1. Enterprise Products Partners LP (EPD) - 1,111,741 shares, 9.26% of the total portfolio. Shares reduced by 9.83%
  2. Apple Inc (AAPL) - 204,918 shares, 8.88% of the total portfolio. Shares reduced by 10.99%
  3. Qualcomm Inc (QCOM) - 504,857 shares, 8.73% of the total portfolio. Shares reduced by 8.24%
  4. Alphabet Inc (GOOG) - 30,089 shares, 7.53% of the total portfolio. Shares reduced by 9.26%
  5. Kinder Morgan Inc (KMI) - 1,018,250 shares, 6.68% of the total portfolio. Shares reduced by 9.64%
New Purchase: Celgene Corp (CELG)

Penn Davis Mcfarland Inc initiated holdings in Celgene Corp. The purchase prices were between $111.53 and $126.88, with an estimated average price of $119.67. The stock is now traded at around $123.54. The impact to the portfolio due to this purchase was 2.62%. The holdings were 69,716 shares as of 2017-03-31.

New Purchase: Bristol-Myers Squibb Company (BMY)

Penn Davis Mcfarland Inc initiated holdings in Bristol-Myers Squibb Company. The purchase prices were between $46.82 and $60.13, with an estimated average price of $54.85. The stock is now traded at around $53.53. The impact to the portfolio due to this purchase was 2.29%. The holdings were 139,558 shares as of 2017-03-31.

Sold Out: Teva Pharmaceutical Industries Ltd (TEVA)

Penn Davis Mcfarland Inc sold out the holdings in Teva Pharmaceutical Industries Ltd. The sale prices were between $32.09 and $37.96, with an estimated average price of $34.13.

Sold Out: Skechers USA Inc (SKX)

Penn Davis Mcfarland Inc sold out the holdings in Skechers USA Inc. The sale prices were between $22.54 and $29.96, with an estimated average price of $25.92.

Sold Out: Chevron Corp (CVX)

Penn Davis Mcfarland Inc sold out the holdings in Chevron Corp. The sale prices were between $106.28 and $117.85, with an estimated average price of $112.17.

Sold Out: Fitbit Inc (FIT)

Penn Davis Mcfarland Inc sold out the holdings in Fitbit Inc. The sale prices were between $5.39 and $8.12, with an estimated average price of $6.34.

Sold Out: HCP Inc (HCP)

Penn Davis Mcfarland Inc sold out the holdings in HCP Inc. The sale prices were between $29.51 and $32.79, with an estimated average price of $30.71.



Here is the complete portfolio of PENN DAVIS MCFARLAND INC. Also check out:

1. PENN DAVIS MCFARLAND INC's Undervalued Stocks
2. PENN DAVIS MCFARLAND INC's Top Growth Companies, and
3. PENN DAVIS MCFARLAND INC's High Yield stocks
4. Stocks that PENN DAVIS MCFARLAND INC keeps buying